Cargando…

Clinical performances of an ELISA for SARS-CoV-2 antibody assay and correlation with neutralization activity

Detalles Bibliográficos
Autores principales:	Padoan, Andrea, Zuin, Silvia, Cosma, Chiara, Basso, Daniela, Plebani, Mario, Bonfante, Francesco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7431325/ https://www.ncbi.nlm.nih.gov/pubmed/32818490 http://dx.doi.org/10.1016/j.cca.2020.08.024

Ejemplares similares

Two rapid SARS-CoV-2 disposable devices for semi-quantitative S-RBD antibody levels determination compared with CLIA and ELISA assays at different protective thresholds
por: Padoan, Andrea, et al.
Publicado: (2022)

Analytical and clinical performances of five immunoassays for the detection of SARS-CoV-2 antibodies in comparison with neutralization activity
por: Padoan, Andrea, et al.
Publicado: (2020)

SARS-CoV-2 neutralizing antibodies after one or two doses of Comirnaty (BNT162b2, BioNTech/Pfizer): Kinetics and comparison with chemiluminescent assays
por: Padoan, Andrea, et al.
Publicado: (2021)

IgA-Ab response to spike glycoprotein of SARS-CoV-2 in patients with COVID-19: A longitudinal study
por: Padoan, Andrea, et al.
Publicado: (2020)

Not all SARS-CoV-2 IgG and neutralizing antibody assays are created equal
por: Lippi, Giuseppe, et al.
Publicado: (2022)

Salivary SARS-CoV-2 antigen rapid detection: A prospective cohort study
por: Basso, Daniela, et al.
Publicado: (2021)

Protective SARS-CoV-2 Antibody Response in Children With Inflammatory Bowel Disease
por: Bosa, Luca, et al.
Publicado: (2022)

Antibody response to first and second dose of BNT162b2 in a cohort of characterized healthcare workers
por: Padoan, Andrea, et al.
Publicado: (2021)

Diagnostic performances and thresholds: The key to harmonization in serological SARS-CoV-2 assays?
por: Plebani, Mario, et al.
Publicado: (2020)

SARS-CoV-2 Infection in Spondyloarthritis Patients Treated With Biotechnological Drugs: A Study on Serology
por: Ortolan, Augusta, et al.
Publicado: (2021)

Presepsin in risk stratification of SARS-CoV-2 patients
por: Zaninotto, Martina, et al.
Publicado: (2020)

The presence of anti–SARS-CoV-2 antibodies does not necessarily reflect efficient neutralization
por: Lippi, Giuseppe, et al.
Publicado: (2022)

Long-term Immune Response to SARS-CoV-2 Infection Among Children and Adults After Mild Infection
por: Di Chiara, Costanza, et al.
Publicado: (2022)

The University of Padua salivary-based SARS-CoV-2 surveillance program minimized viral transmission during the second and third pandemic wave
por: Basso, Daniela, et al.
Publicado: (2022)

Inflammation and Pancreatic Cancer: Focus on Metabolism, Cytokines, and Immunity
por: Padoan, Andrea, et al.
Publicado: (2019)

A cell-based ELISA as surrogate of virus neutralization assay for RBD SARS-CoV-2 specific antibodies
por: Pi-Estopiñan, Franciscary, et al.
Publicado: (2022)

Utility of Different Surrogate Enzyme-Linked Immunosorbent Assays (sELISAs) for Detection of SARS-CoV-2 Neutralizing Antibodies
por: Kohmer, Niko, et al.
Publicado: (2021)

Evaluation of commercially available fully automated and ELISA-based assays for detecting anti-SARS-CoV-2 neutralizing antibodies
por: Zedan, Hadeel T., et al.
Publicado: (2022)

Vaccine Ab neutralization against Omicron and SARS-CoV-2 variants using neutralization and specific ELISA assays
por: Ferré, Valentine Marie, et al.
Publicado: (2022)

Multiplex assessment of SARS-CoV-2 antibodies improves assay sensitivity and correlation with neutralizing antibodies
por: Cook, Nathan, et al.
Publicado: (2021)

Asymptomatic and Mild SARS-CoV-2 Infections Elicit Lower Immune Activation and Higher Specific Neutralizing Antibodies in Children Than in Adults
por: Petrara, Maria Raffaella, et al.
Publicado: (2021)

A Simple and High-Throughput ELISA-Based Neutralization Assay for the Determination of Anti-Flavivirus Neutralizing Antibodies
por: Balingit, Jean Claude, et al.
Publicado: (2020)

A Novel In-Cell ELISA Assay Allows Rapid and Automated Quantification of SARS-CoV-2 to Analyze Neutralizing Antibodies and Antiviral Compounds
por: Schöler, Lara, et al.
Publicado: (2020)

SARS-CoV-2-Neutralizing Antibody Response and Correlation of Two Serological Assays with Microneutralization
por: Souiri, Amal, et al.
Publicado: (2023)

An ELISA Platform for the Quantitative Analysis of SARS-CoV-2 RBD-neutralizing Antibodies As an Alternative to Monitoring of the Virus-Neutralizing Activity
por: Kostin, N. N., et al.
Publicado: (2022)

High concordance of ELISA and neutralization assays allows for the detection of antibodies to individual AAV serotypes
por: Gardner, Matthew R., et al.
Publicado: (2022)

Detection and Quantification of SARS-CoV-2 Receptor Binding Domain Neutralization by a Sensitive Competitive ELISA Assay
por: Shalash, Ahmed O., et al.
Publicado: (2021)

Evaluation of a commercial ELISA as alternative to plaque reduction neutralization test to detect neutralizing antibodies against SARS-CoV-2
por: Hofmann, Natalie, et al.
Publicado: (2022)

A novel competition ELISA for the rapid quantification of SARS‐CoV‐2 neutralizing antibodies in convalescent plasma
por: Wouters, Elise, et al.
Publicado: (2021)

Cardiac troponin I in SARS-CoV-2-patients: The additional prognostic value of serial monitoring
por: Zaninotto, Martina, et al.
Publicado: (2020)

W102 Correlation between the atellica SARS-COV-2 IGG assay results and the presence of SARS-COV-2 neutralizing antibodies
por: Bedini, J., et al.
Publicado: (2022)

Correlation between a quantitative anti‐SARS‐CoV‐2 IgG ELISA and neutralization activity
por: Dolscheid‐Pommerich, Ramona, et al.
Publicado: (2021)

SARS-CoV-2 antibodies titration: a reappraisal
por: Lippi, Giuseppe, et al.
Publicado: (2020)

Overview of Neutralization Assays and International Standard for Detecting SARS-CoV-2 Neutralizing Antibody
por: Liu, Kuan-Ting, et al.
Publicado: (2022)

Endothelial dysfunction and Mid-Regional proAdrenomedullin: What role in SARS-CoV-2 infected Patients?
por: Zaninotto, Martina, et al.
Publicado: (2021)

Salivary proteomic analysis in asymptomatic and symptomatic SARS-CoV-2 infection: Innate immunity, taste perception and FABP5 proteins make the difference
por: Aita, Ada, et al.
Publicado: (2022)

SARS-CoV-2 antibody-based SURVEILLANCE: New light in the SHADOW
por: Plebani, Mario
Publicado: (2020)

ELISA detection of SARS-CoV-2 antibodies in saliva
por: MacMullan, Melanie A., et al.
Publicado: (2020)

Establishment and clinical validation of an in-cell-ELISA-based assay for the rapid quantification of Rabies lyssavirus neutralizing antibodies
por: Schöler, Lara, et al.
Publicado: (2022)

A quantitative assay for detection of SARS-CoV-2 neutralizing antibodies
por: Cerutti, Helena, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5ub3m9e37va54s4cff4tp2rlej